Viemed Healthcare (NASDAQ:VMD - Get Free Report) is set to release its earnings data after the market closes on Wednesday, November 6th. Viemed Healthcare has set its Q3 2024 guidance at EPS.Individual interested in registering for the company's earnings conference call can do so using this link.
Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.07 by ($0.03). The firm had revenue of $54.97 million for the quarter. Viemed Healthcare had a return on equity of 8.23% and a net margin of 4.60%.
Viemed Healthcare Stock Performance
Shares of NASDAQ:VMD traded down $0.17 during midday trading on Wednesday, reaching $8.88. The company's stock had a trading volume of 209,624 shares, compared to its average volume of 145,748. Viemed Healthcare has a twelve month low of $5.90 and a twelve month high of $10.44. The company has a quick ratio of 1.29, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $344.77 million, a PE ratio of 37.29 and a beta of 1.47. The stock has a fifty day moving average of $7.97 and a 200 day moving average of $7.45.
Viemed Healthcare Company Profile
(
Get Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Stories
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.